Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCAT2 | O15382 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.51 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.51 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.51 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.50 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.50 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.50 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.50 |
| ▸ | ATM | Q13315 | 2/20 | 0.48 |
| ▸ | CDC25B | P30305 | 2/20 | 0.48 |
| ▸ | HNF4A | P41235 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL134291 | 0.98 | BCAT2 (0.59) | BCAT2MEN1KMT2ASMN1; SMN2MAPK13 | |
| SCHEMBL22414007 | 0.90 | ATM (0.57) | BCAT2MEN1KMT2ASMN1; SMN2MAPK13 | |
| Benzophenone SCHEMBL27513399 | 0.90 | ALDH1A1 (0.61) | BCAT2MEN1KMT2ASMN1; SMN2MAPK13 | |
| SCHEMBL12551543 | 0.89 | PTPN1 (0.53) | BCAT2MEN1KMT2ASMN1; SMN2MAPK13 | |
| SCHEMBL28062549 | 0.88 | ALDH1A1 (0.59) | BCAT2MEN1KMT2ASMN1; SMN2MAPK13 | |
| SCHEMBL13191852 | 0.88 | BCAT2 (0.49) | BCAT2MEN1KMT2ASMN1; SMN2MAPK13 | |
| SCHEMBL12187086 | 0.88 | BCAT2 (0.49) | BCAT2MEN1KMT2ASMN1; SMN2MAPK13 | |
| SCHEMBL472751 | 0.88 | ALDH1A1 (0.63) | BCAT2MEN1KMT2ASMN1; SMN2MAPK13 | |
| SCHEMBL5549354 | 0.85 | BCAT2 (0.68) | BCAT2MEN1KMT2ASMN1; SMN2MAPK13 | |
| SCHEMBL30791463 | 0.84 | CDC25B (0.69) | BCAT2MEN1KMT2ASMN1; SMN2MAPK13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11535640-B2 | Metal complexes | MERCK PATENT GMBH (DE) | 2022-12-27 | — | — | US | disclosed |
| EP-2984152-B2 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2022-01-05 | — | — | EP | disclosed |
| EP-3658564-B1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2021-05-19 | — | — | EP | disclosed |
| US-20200207794-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2020-07-02 | — | — | US | disclosed |
| EP-2627730-B1 | FORMULATIONS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2020-05-06 | — | — | EP | disclosed |
| US-10636990-B2 | Organic electroluminescence device | MERCK PATENT GMBH (DE) | 2020-04-28 | — | — | US | disclosed |
| EP-2748878-B1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2020-04-01 | — | — | EP | disclosed |
| US-20200052213-A1 | BINUCLEAR METAL COMPLEXES AND ELECTRONIC DEVICES, IN PARTICULAR ORGANIC ELECTROLUMINESCENT DEVICES CONTAINING SAID METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2020-02-13 | — | — | US | disclosed |
| EP-2984152-B1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2018-04-25 | — | — | EP | disclosed |
| US-20170309855-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2017-10-26 | — | — | US | disclosed |
| US-20120056169-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH PATENTS & SCIENTIFIC INFORMATION (DE) | 2012-03-08 | — | — | US | disclosed |
| US-20120056169-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH PATENTS & SCIENTIFIC INFORMATION (DE) | 2012-03-08 | — | — | US | disclosed |
| US-20120037896-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2012-02-16 | — | — | US | disclosed |
| US-20120037896-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2012-02-16 | — | — | US | disclosed |
| US-20110284831-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2011-11-24 | — | — | US | disclosed |
| US-20110284831-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2011-11-24 | — | — | US | disclosed |
| US-20110140043-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2011-06-16 | — | — | US | disclosed |
| US-20110140043-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2011-06-16 | — | — | US | disclosed |
| US-20110108818-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2011-05-12 | — | — | US | disclosed |
| US-20110108818-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2011-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110140043-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICE | L1CAM, SLCO4C1, GJA1 | BCAT2 1930/4885MEN1 327/4885KMT2A 3543/4885 |
| US-20200207794-A1 | METAL COMPLEXES | IMMT, MCU, SOD1 | BCAT2 2932/4885MEN1 2301/4885KMT2A 4304/4885 |
| US-11535640-B2 | Metal complexes | IMMT, MCU, SOD1 | BCAT2 2932/4885MEN1 2301/4885KMT2A 4304/4885 |
| US-20200052213-A1 | BINUCLEAR METAL COMPLEXES AND ELECTRONIC DEVICES, IN PARTICULAR ORGANIC ELECTROLUMINESCENT DEVICES CONTAINING SAID METAL COMPLEXES | BICRA, NCLN, IMMT | BCAT2 2262/4885MEN1 1465/4885KMT2A 2649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.